Mometasone Topical Dosage
Medically reviewed by Drugs.com. Last updated on Aug 9, 2023.
Applies to the following strengths: 0.1%
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Dermatitis
Apply a thin layer to the affected area once a day
Comments:
- This topical drug should not be used with occlusive dressings unless directed by a healthcare provider.
- Therapy should be discontinued when control is obtained.
- If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.
Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Usual Adult Dose for Eczema
Apply a thin layer to the affected area once a day
Comments:
- This topical drug should not be used with occlusive dressings unless directed by a healthcare provider.
- Therapy should be discontinued when control is obtained.
- If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.
Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Usual Adult Dose for Psoriasis
Apply a thin layer to the affected area once a day
Comments:
- This topical drug should not be used with occlusive dressings unless directed by a healthcare provider.
- Therapy should be discontinued when control is obtained.
- If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.
Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Usual Pediatric Dose for Dermatitis
2 years and older:
Cream/ointment: Apply a thin layer to the affected area once a day
12 years and older:
Lotion: Apply a thin layer to the affected area once a day
Comments:
- Safety and efficacy in pediatric patients for more than 3 weeks of use have not been established.
- This topical drug should not be applied in the diaper area if the child still requires diapers or plastic pants.
- Therapy should be discontinued when control is obtained.
- If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.
Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Usual Pediatric Dose for Eczema
2 years and older:
Cream/ointment: Apply a thin layer to the affected area once a day
12 years and older:
Lotion: Apply a thin layer to the affected area once a day
Comments:
- Safety and efficacy in pediatric patients for more than 3 weeks of use have not been established.
- This topical drug should not be applied in the diaper area if the child still requires diapers or plastic pants.
- Therapy should be discontinued when control is obtained.
- If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.
Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Usual Pediatric Dose for Psoriasis
2 years and older:
Cream/ointment: Apply a thin layer to the affected area once a day
12 years and older:
Lotion: Apply a thin layer to the affected area once a day
Comments:
- Safety and efficacy in pediatric patients for more than 3 weeks of use have not been established.
- This topical drug should not be applied in the diaper area if the child still requires diapers or plastic pants.
- Therapy should be discontinued when control is obtained.
- If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.
Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
Safety and efficacy have not been established in patients younger than 2 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- The treated area should not be bandaged, covered, or wrapped, as to be occlusive, unless directed by a healthcare provider.
- Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area.
Monitoring:
- Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)
Patient advice:
- Use should be avoided on the face, groin, or axillae.
- Patients should report any signs of local adverse reactions, especially those that develop under occlusive dressings.
- This medication is to be used as directed by the physician.
- Patients should be advised not to use this medication for any condition other than for which it was prescribed.
- Lotion should not be used in the treatment of diaper dermatitis.
More about mometasone topical
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (91)
- Side effects
- During pregnancy
- Drug class: topical steroids
- En español
Patient resources
Other brands
Professional resources
- Mometasone (Topical) monograph
- Mometasone Cream (FDA)
- Mometasone Lotion (FDA)
- Mometasone Ointment (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.